CD8A and breast carcinoma: Similarly, in human breast cancer, the presence of tumor‐specific CD8+TRM cells—rather than the total CD8+T cell population—has been linked to delayed metastatic relapse following tumor resection, emphasizing their functional relevance in preventing metastasis [25].